Home / Journals / CJU / Vol.17, No.4, 2010
Special Issues
Table of Content
  • Open AccessOpen Access

    EDITORIAL

    Expectant Management - What is “limited life expectancy”

    Thomas W. Jarrett
    Canadian Journal of Urology, Vol.17, No.4, pp. 5245-5245, 2010
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    BOOK REVIEW

    Human Papillomavirus: A Practical Guide for Urologists

    Rosenblatt, Alberto, Campos Guidi, Homero Gustavo de
    Canadian Journal of Urology, Vol.17, No.4, pp. 5246-5246, 2010
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    LEGENDS IN UROLOGY

    LEGENDS IN UROLOGY - AN OBITUARY

    Richard D. Williams
    Canadian Journal of Urology, Vol.17, No.4, pp. 5247-5248, 2010
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    REVIEW

    Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature

    Bob Djavan1, Elisabeth Eckersberger1, Markus Johannes Handl2, Roland Brandner1, Helen Sadri1, Herbert Lepor1
    Canadian Journal of Urology, Vol.17, No.4, pp. 5249-5254, 2010
    Abstract Background: Transurethral resection of the prostate (TURP) has been the gold standard of the treatment of benign prostatic hyperplasia (BPH). In recent years there has been a significant shift in the treatment of BPH and guidelines emphasize minimally invasive surgery as a new treatment option. Minimal invasive technologies (MITs), such as transurethral microwave thermotherapy (TUMT), laser ablations, transurethral needle ablation (TUNA) have emerged as an alternative to the TURP.
    Objectives: To assess the retreatment rates of the most commonly used minimal invasive techniques.
    Search strategy: Durability articles were selected by using defined search terms using PubMed as search engine.
    More >

  • Open AccessOpen Access

    ARTICLE

    Effect of modifi ed suprapubic prostatectomy for benign prostatic hyperplasia on postoperative hemoglobin levels

    Chukwudi O. Okorie1, Louis L. Pisters2
    Canadian Journal of Urology, Vol.17, No.4, pp. 5255-5258, 2010
    Abstract Objectives: Hemostasis during suprapubic prostatectomy for benign prostatic hyperplasia (BPH) is commonly affected by placing sutures at the 5 o'clock position and the 7 o'clock position of the bladder neck. However, the urethral arterial branches of the inferior vesical artery that supplies the prostate extend from the 1 o'clock to 5 o'clock position and from the 7 o'clock to 11 o'clock position of the bladder neck, with the largest branches located posteriorly. This study analyses the effect of a modified suprapubic prostatectomy technique, which covered the area from the 1 o'clock position to the 11 o'clock… More >

  • Open AccessOpen Access

    ARTICLE

    Association between erectile function and lower urinary tract symptoms in patients treated with permanent seed prostate brachytherapy

    Daniel Taussky1, Guila Delouya1, Fabio Lefebvre1, Aihua Liu2, Michal Abrahamowicz2, Jean-Paul Bahary1, David Donath1
    Canadian Journal of Urology, Vol.17, No.4, pp. 5259-5264, 2010
    Abstract Purpose: Among men who underwent permanent seed prostate brachytherapy, we aimed to: 1) investigate whether development of lower urinary tract symptoms (LUTS) after permanent seed prostate brachytherapy was associated with suboptimal erectile function before brachytherapy, and 2) identify factors that are associated with normal erectile function before brachytherapy.
    Methods and materials: We analyzed data from 215 consecutive patients with low-or intermediate-risk prostate cancer who received permanent seed brachytherapy at our center. Erectile function at baseline (prior to brachytherapy) was assessed using the Mount Sinai Erectile Function Score (MSEFS). Urinary symptoms at baseline and at 1 month and… More >

  • Open AccessOpen Access

    ARTICLE

    Analysis of testosterone suppression in men receiving histrelin, a novel GnRH agonist for the treatment of prostate cancer

    Bob Djavan1, Peter Schlegel2, Georg Salomon3, Elisabeth Eckersberger1, Helen Sadri1, Markus Graefen3
    Canadian Journal of Urology, Vol.17, No.4, pp. 5265-5271, 2010
    Abstract Background: Androgen deprivation therapy (ADT) is the standard care in men with advanced prostate cancer. Continuous testosterone suppression is essential to treatment efficacy. Recently a 1 year depot compound histrelin, (VANTAS; Orion Pharmaceuticals, Finland; Endo Pharmaceuticals, USA), a gonadotropin-releasing hormone (GnRH) analog, was approved for hormone therapy of prostate cancer. In the present study the therapeutic efficacy of this compound was investigated, in addition to its impact on testosterone values and velocity as well as PSA.
    Method: One hundred thirty-one patients with histologically confirmed prostate cancer and normal testosterone levels were prospectively evaluated over 1 year. Androgen… More >

  • Open AccessOpen Access

    ARTICLE

    The effect of local compression and topical epinephrine on perioperative bleeding and degree of urinary extravasation on postoperative cystogram following radical retropubic prostatectomy

    Rena Malik, Juliana Laze, Herbert Lepor
    Canadian Journal of Urology, Vol.17, No.4, pp. 5272-5277, 2010
    Abstract Objective: To evaluate the efficacy of local compression and topical epinephrine in controlling perioperative bleeding during open radical retropubic prostatectomy (ORRP) and its impact on the degree of urinary extravasation on initial postoperative cystogram.
    Methods: Between September 2005 to March 2009, 476 men underwent ORRP performed by a single surgeon. Group 1 (n = 200) underwent ORRP between September 2005 and November 2006 without pelvic compression; Group 2 (n = 76) underwent ORRP between November 2006 and May 2007 and a dry laparotomy pad was positioned in the pelvis immediately prior to abdominal wound closure; Group 3… More >

  • Open AccessOpen Access

    ARTICLE

    Lower urinary tract leiomyoma: is excision necessary?

    Deborah J. Lightner, Bryan C. Bruner
    Canadian Journal of Urology, Vol.17, No.4, pp. 5278-5282, 2010
    Abstract Introduction/objectives: Our objective was to review our experience with lower urinary tract leiomyomata to determine if presentation, exam and imaging allows for stratification of the treatment of this rare lesion.
    Materials and methods: A retrospective review of current practice was performed from the Mayo Clinic Rochester database identifying 13 female patients and 10 males from 1995-2008, focusing on the clinical presentation, cystoscopic findings, imaging and operative approaches.
    Results: Symptomatic patients had larger lesions, were more likely to be females, or had midline periurethral or bladder neck lesions. Cystoscopic findings were uniformly described as submucosal polypoid lesions without surrounding… More >

  • Open AccessOpen Access

    ARTICLE

    Effects of combined behavioral intervention and tolterodine on patient-reported outcomes

    Jean F. Wyman1, Carl Klutke2, Kathryn Burgio3, Zhonghong Guan4, Franklin Sun4, Sandra Berriman4, Tamara Bavendam4
    Canadian Journal of Urology, Vol.17, No.4, pp. 5283-5290, 2010
    Abstract Objective: To assess the effects of tolterodine extended release (ER) plus behavioral intervention on urgency and other patient-reported outcomes in subjects with overactive bladder (OAB) who were previously dissatisfied with antimuscarinic treatment.
    Methods: In this 16-week, multicenter, open-label study, eligible adults (aged ≥ 18 y) reported dissatisfaction with their most recent antimuscarinic OAB medication; ≥ 8 micturitions and ≥ 2 urgency episodes per 24 hours and ≥ 1 UUI episode in 5 day bladder diaries; and OAB symptoms for ≥ 3 months. Subjects received tolterodine ER plus a behavioral educational handout with verbal reinforcement of behavioral intervention… More >

  • Open AccessOpen Access

    MINIMALLY INVASIVE AND ROBOTIC SURGERY

    High body mass index does not affect outcomes following robotic assisted laparoscopic prostatectomy

    Daniel J. Moskovic, Hugh J. Lavery, Jamil Rehman, Fatima Nabizada-Pace, Jonathan Brajtbord, David B. Samadi
    Canadian Journal of Urology, Vol.17, No.4, pp. 5291-5298, 2010
    Abstract Introduction: Given the anatomic constraints of obese patients, concern exists as to whether robotic assisted laparoscopic prostatectomy (RALP) is appropriate in patients with higher body mass index (BMI). We reviewed a large RALP database to determine if clinical outcomes are related to BMI.
    Methods: The records of patients who underwent a RALP from 2003-2009 were reviewed. BMI stratifications were concordant with the Centers for Disease Control (CDC) standards: ≥ 30, ≥ 25 and < 30, and < 25 were classified as obese, overweight, and normal weight, respectively. Baseline, perioperative, histopathologic, and functional outcome data were collected.
    Results: A… More >

  • Open AccessOpen Access

    MINIMALLY INVASIVE AND ROBOTIC SURGERY

    Experience with robotic assisted laparoscopic surgery in upper tract urolithiasis

    Ashok K. Hemal1, Rishi Nayyar2, Narmada P. Gupta2, Lalgudi N. Dorairajan1
    Canadian Journal of Urology, Vol.17, No.4, pp. 5299-5305, 2010
    Abstract Objective: Early results indicate that robot assisted laparoscopic surgery (RALS) may be useful in managing upper tract (UT) urolithiasis. We reviewed our experience of managing 50 cases of UT urolithiasis with or without reconstruction using RALS.
    Materials and methods: We performed a record review of 50 cases of RALS for UT urolithiasis performed in two institutions from July 2006 to June 2009. The RALS procedures included pyeloplasty with pyelolithotomy (29 cases), ureterolithotomy, tailoring and reimplantation for megaureters (5 cases), ureterolithotomy with ureteral stricture reconstruction (1 case), primary UT stone surgeries (8 cases), partial nephrectomy (1 case) and… More >

  • Open AccessOpen Access

    CASE REPORT

    Orchitis in lupus/scleroderma overlap syndrome: a case report and literature review

    Eman R. Boulis, Vikas Majithia
    Canadian Journal of Urology, Vol.17, No.4, pp. 5306-5308, 2010
    Abstract Testicular involvement in connective tissue diseases (CTD) is typically caused by medium vessel vasculitis as in polyarteritis nodosa. Systemic lupus erythrematosus (SLE) and systemic sclerosis cause small vessel vasculitis, which is an unusual cause of orchitis. We hereby report a case of orchitis in a 28-year-old patient caused by vasculitis related to his lupus/scleroderma overlap CTD. He had an excellent response to steroids and azathioprine with complete resolution of his testicular and systemic symptoms. Our case highlights that although testicular involvement secondary to small vessel vasculitis in CTD is uncommon, it is still possible and More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Metanephric adenofibroma: robotic partial nephrectomy of a large Wilms’ tumor variant

    Zachary Piotrowski1, Daniel J. Canter2, Alexander Kutikov2, Tahseen Al-Saleem3,4, Jianming Pei5, Joseph R. Testa4,6, Robert G. Uzzo2
    Canadian Journal of Urology, Vol.17, No.4, pp. 5309-5312, 2010
    Abstract Purpose: A case of the rare, benign, Wilms’ tumor (WT) variant, metanephric adenofibroma (MAF), is presented.
    Materials and methods: The patient is a 21-year-old female with an incidentally discovered enhancing renal mass. The diagnosis, workup and treatment are outlined.
    Results: The 19 cm renal mass was ultimately resected via robot-assisted partial nephrectomy. Pathologic diagnosis at our institution was confirmed as a MAF by the National Wilms’ Tumor Study Group (NWTSG).
    Conclusion: Difficult to differentiate from WT, it is imperative that MAF be recognized and appropriately diagnosed because unlike adult WT, the natural history of MAF is indolent and adjuvant More >

  • Open AccessOpen Access

    ABSTRACT

  • Open AccessOpen Access

    CLINICAL TRIALS

    Offi ce based urology trials

    Richard W. Casey1, Jack Barkin2
    Canadian Journal of Urology, Vol.17, No.4, pp. 5334-5337, 2010
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    CLINICAL TRIALS

    Open clinical uro-oncology trials in Canada

    Eric Winquist, George Rodrigues
    Canadian Journal of Urology, Vol.17, No.4, pp. 5338-5342, 2010
    Abstract This article has no abstract. More >

Per Page:

Share Link